Biotage has established a new office in Singapore in line with a long-standing strategy of operating as close to the customer as possible. Direct presence in the region will enhance sales, service and support capacity in relation to Biotage’s customers, while also providing important local insights to the benefit of further development of products and solutions. This is in line with the customer centric approach that the company is following.

Biotage’s new office in Singapore will service end customers and distributors in all the member countries of ASEAN (the Association of South East Asian Nations). This follows a well-established strategy to be as close to customers as possible. Once there is a critical mass for the company’s business in a region, a direct presence is established locally. The present expansion builds further upon Biotage’s established Asian offices in Japan, China, Korea and India.

“Biotage subscribes to the principal of thinking globally and acting locally. Being present in a region not only sets better preconditions for presenting customers with our full range of products, solutions, and services. It also gives customers the opportunity to connect with Biotage staff sharing similar culture, language, and mentality. Proximity also brings us local insights and the ability to base our decision-making on facts and customer needs established on the ground. It is truly a win-win situation,” said Tomas Blomquist, CEO of Biotage.

In the ASEAN region, Biotage has a growing business within all its three customer focus areas: White Tech (pharmaceutical R&D and manufacturing), Red Tech (diagnostics companies and clinical, forensic and doping labs) and Blue & Green Tech (environmental, water and food labs). Red Tech and Blue & Green Tech are particularly strong areas for Biotage in the region. With the Singapore office in place there is an even more significant growth potential in the years to come.

Singapore was seen as a suitable regional hub for Biotage. This pivotal center for business and free trade provides easy transportation, a well-structured and stable economy as well as a top-notch education system, facilitating recruitment.

Contacts

Tomas Blomquist, President and CEO
Tel: 0705 23 01 63, tomas.blomquist@biotage.com

About Biotage

Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Website: www.biotage.com

Attachments

Biotage sets up business in Singapore to better serve the ASEAN region

© Modular Finance, source Nordic Press Releases